Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Input: Consider Input: Paragraph: Since Nov. 1, South Carolina has recorded 86 reported cases of the contagious disease. State Epidemiologist Linda Bell said Monday that’s more than four times what state officials normally expect to see. Over the last 10 years, South Carolina averaged 19 reported cases of hepatitis A annually. Most of the new cases have occurred in Aiken County, and almost half of all cases involve individuals who reported drug use, Bell said. Still, the general population needn’t be overly concerned, she said. “But we are seeing cases higher that what we expect to see,” Bell said. “And so it’s important for us to do our prevention efforts early to reach those high-risk groups, get them vaccinated ... so that we can prevent” a severe outbreak. The State reports the Department of Health and Environmental Control is offering no-cost vaccines to high risk groups including drug users, homeless, formerly incarcerated and sexually-active gay men. Additionally, health officials recommend all children get two doses of the vaccine as part of their immunization schedule. Of the 86 reported cases in South Carolina, 59 have led to hospitalization and one resulted in death, the DHEC said. Hepatitis is a disease characterized by inflammation of the liver. It comes in many forms, including hepatitis A, B and C. As a result, individuals with chronic liver disease, like cirrhosis, are at increased risk of complications if infected and should be vaccinated. The virus-borne infection can be prevented by vaccination and is usually transmitted person-to-person through consumption of contaminated food or water, according to the U.S. Centers for Disease Control and Prevention. Antibodies produced in response to hepatitis A infection last for life and protect against reinfection. Infection usually results in sickness in two to six weeks after exposure. Symptoms include fatigue, loss of appetite, stomach pain, nausea, and yellowing of the eyes and skin. Symptoms usually resolve within two months of infection, according to the CDC. State public health officials in February declared an outbreak in Aiken County after an employee at a second restaurant in Aiken tested positive for the virus, the DHEC said. Bell, though, stressed transmission by food or beverage is uncommon. “Most transmission in the United States is through person-to-person contact,” Bell said. “Good hygiene - diligently washing your hands - is a good way to prevent hepatitis A, as well as not sharing personal items,” including drug equipment, she said, adding the state has received reports of hepatitis A from people using various drugs, “everything from marijuana to meth.” Residents can schedule an appointment for a vaccination at their local health department by calling 855-472-3432 or going to http://bit.ly/2HhEsM8 . ___ Information from: The State, http://www.thestate.com Claim: South Carolina declares hepatitis outbreak.

Output: What began as a spike in reported hepatitis A cases in Aiken County has now spread to other parts of South Carolina, prompting public health officials to declare a statewide outbreak.


Input: Consider Input: Paragraph: Older adults who underwent a brief course of brain exercises saw improvements in reasoning skills and processing speed that could be detected as long as 10 years after the course ended, according to results from the largest study ever on cognitive training. The findings, published on Monday in the Journal of the American Geriatrics Society, offer welcome news in the search for ways to keep the mind sharp as 76 million baby boomers in the United States advance into old age. The federally sponsored trial of almost 3,000 older adults, called the Advanced Cognitive Training for Independent and Vital Elderly study, or ACTIVE, looked at how three brain training programs - focusing on processing speed, memory and reasoning ability - affected cognitively normal adults as they aged. People in the study had an average age of 74 when they started the training, which involved 10 to 12 sessions lasting 60 to 75 minutes each. After five years, researchers found, those with the training performed better than their untrained counterparts in all three measures. Although gains in memory seen at the study’s five-year mark appeared to drop off over the next five years, gains in reasoning ability and processing speed persisted 10 years after the training. “What we found was pretty astounding. Ten years after the training, there was evidence the effects were durable for the reasoning and the speed training,” said George Rebok, an expert on aging and a professor at Johns Hopkins University in Baltimore, who led the study. Participants in all three training groups also reported that they had an easier time with daily activities such as managing their medications, cooking meals or handling their finances than did participants who did not get the training. But standard tests of these activities showed no differences between the groups. “The speed-of-processing results are very encouraging,” said study co-author Jonathan King, program director for cognitive aging in the Division of Behavioral and Social Research at the National Institute on Aging (NIA), part of the National Institutes of Health, which helped fund the research. King said the self-reported improvements in daily function were interesting, but added, “We do not yet know whether they would truly allow older people to live independently longer.”  However, researchers said even a small gain would be likely to ease the burden on caregivers and healthcare providers. “If we delay the onset of difficulties in daily activities even by a small amount, that can have major public health implications in terms of helping to curb healthcare costs, delaying entry into institutions and hospitals,” Rebok said. The training course was designed to bolster specific cognitive abilities that begin to slip as people age. It does not aim to prevent dementia caused by underlying disease such as Alzheimer’s. At the start of the study, all 2,832 participants were cognitively normal. The study included four groups: three training groups plus a control group of volunteers who came in for regular testing to see how they were faring with age. People were trained in small groups over a period of several weeks and then were tested immediately after the training and again one, two, three, five and 10 years later. About 60 percent of the volunteers who underwent training also got booster training sessions, which enhanced the initial benefits. At the end of the trial, all groups showed declines compared with their initial baseline tests in memory, reasoning and processing speed, but those who got training in reasoning and processing speed experienced less decline. Among those given training in reasoning strategies, 73.6 percent were still performing above their pre-trial baseline level, compared with 61.7 percent of those who received no training and were only benefiting from practice on the test. The effect was even greater in processing speed. Among the training group, 70.7 percent of participants were performing at or above their baseline level, compared with 48.8 percent of those in the control group. There was no difference in memory performance between the memory group and the control group after 10 years. Two of the three training programs - the memory and the reasoning strategies - were done with paper and pencil, while the processing speed training was done on a computer. The programs, developed by the researchers, were focused largely on teaching strategies to improve cognitive performance. For example, the memory training taught people how to remember word lists, sequences and main ideas, while the reasoning training focused on things like recognizing number patterns. In the processing speed training, people were asked to focus on the main object in a computer screen while also trying to quickly recognize and identify objects on the periphery of the screen. Such training can help older drivers with things like recognizing road signs while driving. A version of the speed training program developed for this trial is now commercially available through the brain fitness company Posit Science, but the researchers are working on making other types of training available as well. Rebok’s team just got a grant from the National Institute on Aging to make a computerized version of the memory test, with the hope that repeated training can improve the results. The study was not designed to explain why cognitive training can have such a lasting effect. Rebok said it may be that people take the strategies they learn and practice them over time. As they age, trained individuals can rely on these strategies to compensate for their declines. Whether this training actually strengthened the brain in the way that exercising builds muscle is not clear, but the government intends to study this, too. Last week, NIA put out a request for proposals that would study whether cognitive training causes physical changes in the brain. Claim: Brain training helped older adults stay sharp for years: study.

Output: A brief course of brain exercises helped older adults hold on to improvements in reasoning skills and processing speed for 10 years after the course ended, according to results from the largest study ever done on cognitive training.


Input: Consider Input: Paragraph: Bayer acquired Monsanto this year for $63 billion. “If we can settle nuisances at some point where the defense costs in preparing cases are higher than potential settlement amounts, we will of course consider it from an economic standpoint,” CEO Werner Baumann told reporters when asked whether there was any scenario in which Bayer would consider settling. He added: “We will resolutely and with all means defend ourselves in this (glyphosate) litigation.”  Baumann was speaking on Monday to German media invited to visit Bayer’s new operations in the former research and development facilities of Monsanto in St. Louis, Missouri. The remarks, made on Monday, were embargoed to the end of the week to allow media to return home. Shares in Bayer have lost 25 percent in value since Aug. 10, when a San Francisco jury awarded $289 million to Dewayne Johnson on grounds Monsanto failed to warn the school groundskeeper and other consumers of the cancer risks posed by glyphosate-based RoundUp and Ranger Pro. Johnson has terminal non-Hodgkin’s lymphoma that he alleges was caused by the herbicides. A judge later reduced the award to $78 million. Bayer denies that glyphosate causes cancer and says decades of scientific studies and real-world use have shown the chemical to be safe for human use. The company is appealing the findings. The number of glyphosate cases that Bayer faces across the United States has jumped to more than 8,700, prompting concerns among investors about the impact of litigation costs on Bayer’s bottom line. Baumann expressed confidence that Bayer could handle the litigation, and cited its “inexpensive” $12 million settlement of 4,000 lawsuits over its contraceptive Mirena device. Bayer also won five of six trials over its best-selling bloodthinner Xarelto, over which it faces 24,000 U.S. lawsuits. The sixth jury found in favor of a plaintiff, but a judge later overturned the decision. “Due to our exposure as a pharmaceutical company, we have the experience to defend those (glyphosate) cases,” he said. Baumann said the company’s legal strategy had been revised following the integration of Bayer and Monsanto in mid-August. He declined to provide details, but recent court filings reveal some of the steps the company has taken. Last week, Bayer added the attorneys from law firm Arnold & Portner who won the Xarelto cases for the company to its glyphosate defense team. It is also trying to change the juror selection process for upcoming trials. In filings last week in San Francisco federal court, where a new glyphosate trial is scheduled to begin on Feb. 25, 2019, Bayer said the “jury pool likely has grown more hostile” due to negative media coverage following the Johnson verdict. Michael Miller, one of the attorneys for the plaintiff, said the company’s claims were “hypocritical beyond belief” given its own efforts to control the message on glyphosate, most recently in a full-page advertisement in the Washington Post. Bayer has asked U.S. District Judge Vince Chhabria, who is overseeing the San Francisco case and some 580 others, to significantly expand the jury pool and question prospective jurors about their knowledge of the media coverage of the cases. Chhabria is expected to decide on the requests in December. Claim: Bayer CEO says would consider glyphosate settlement depending on costs.


Output: Bayer AG’s chief executive said this week the company might consider settling lawsuits over Monsanto’s glyphosate-containing weed-killers depending on how high court costs rise, but stressed it remained focused on defending the combined company against claims they cause cancer.